Phase I study of concurrent motexafin gadolinium (MGd) with radiation therapy for children with newly diagnosed brain stem gliomas (BSG): A Children’s Oncology Group study Article

Bradley, K, Mehta, M, Adamson, P et al. (2006). Phase I study of concurrent motexafin gadolinium (MGd) with radiation therapy for children with newly diagnosed brain stem gliomas (BSG): A Children’s Oncology Group study . JOURNAL OF CLINICAL ONCOLOGY, 24(18_suppl), 9014-9014. 10.1200/jco.2006.24.18_suppl.9014

cited authors

  • Bradley, K; Mehta, M; Adamson, P; Ames, M; Jakacki, R; Vezina, G; Ingle, A; Ivy, P; Blaney, S; Pollack, I

authors

publication date

  • June 20, 2006

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • Cancer
  • Clinical Research
  • Orphan Drug
  • Pediatric
  • Pediatric Research Initiative
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 9014

end page

  • 9014

volume

  • 24

issue

  • 18_suppl